Get the Stockscreener App
58.84
0.05%
-0.03
After Hours:
58.85
0.010
+0.02%
Revolution Medicines Inc stock is traded at $58.84, with a volume of 2.38M.
It is down -0.05% in the last 24 hours and up +26.00% over the past month.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
See More
Previous Close:
$58.87
Open:
$58.96
24h Volume:
2.38M
Relative Volume:
1.15
Market Cap:
$11.00B
Revenue:
$29.52M
Net Income/Loss:
$-567.06M
P/E Ratio:
-16.08
EPS:
-3.66
Net Cash Flow:
$-551.11M
1W Performance:
+8.00%
1M Performance:
+26.00%
6M Performance:
+45.72%
1Y Performance:
+9.98%
1-Day Range:
$58.28
$59.74
1-Week Range:
$55.40
$60.08
52-Week Range:
$29.17
$62.40
Revolution Medicines Inc Stock (RVMD) Company Profile
Name
Revolution Medicines Inc
Sector
Industry
Phone
415-766-3638
Address
700 SAGINAW DR, REDWOOD CITY, CA
Compare RVMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RVMD
Revolution Medicines Inc
|
58.84 | 11.00B | 29.52M | -567.06M | -551.11M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Revolution Medicines Inc Stock (RVMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | Mizuho | Outperform |
| Oct-16-25 | Resumed | Stifel | Buy |
| Sep-12-25 | Resumed | Raymond James | Strong Buy |
| Sep-05-25 | Initiated | Truist | Buy |
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Aug-15-25 | Initiated | Wells Fargo | Overweight |
| Jul-15-25 | Initiated | Goldman | Buy |
| Jul-16-24 | Reiterated | Needham | Buy |
| Jul-12-24 | Initiated | Barclays | Overweight |
| Jul-08-24 | Initiated | Jefferies | Buy |
| Apr-12-24 | Reiterated | Needham | Buy |
| Apr-10-24 | Upgrade | Raymond James | Outperform → Strong Buy |
| Mar-11-24 | Initiated | Piper Sandler | Overweight |
| Jan-05-24 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-04-24 | Initiated | Wedbush | Outperform |
| Nov-16-23 | Initiated | Raymond James | Outperform |
| Feb-28-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-14-22 | Initiated | Needham | Buy |
| Oct-21-22 | Initiated | Oppenheimer | Outperform |
| May-20-22 | Initiated | BofA Securities | Neutral |
| Mar-01-22 | Upgrade | Stifel | Hold → Buy |
| Sep-23-21 | Initiated | Stifel | Hold |
| Aug-12-21 | Downgrade | Goldman | Buy → Neutral |
| May-18-21 | Initiated | Goldman | Buy |
| May-21-20 | Initiated | H.C. Wainwright | Buy |
| Mar-09-20 | Initiated | Cowen | Outperform |
| Mar-09-20 | Initiated | Guggenheim | Buy |
| Mar-09-20 | Initiated | JP Morgan | Neutral |
View All
Revolution Medicines Inc Stock (RVMD) Latest News
Technical signs of recovery in Revolution Medicines Inc. Equity WarrantWeekly Market Report & Safe Entry Point Alerts - newser.com
What MACD and RSI say about Revolution Medicines Inc. Equity WarrantTake Profit & Safe Capital Growth Trade Ideas - newser.com
Is Revolution Medicines Inc. Equity Warrant stock a buy on dipsEarnings Growth Summary & Low Drawdown Investment Ideas - newser.com
Revolution Medicines Inc. Equity Warrant stock retracement – recovery analysisJuly 2025 Macro Moves & Smart Allocation Stock Reports - newser.com
Technical signs of recovery in Revolution Medicines Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - newser.com
Is Revolution Medicines Inc. a candidate for recovery play2025 Pullback Review & Risk Managed Trade Strategies - newser.com
How Revolution Medicines Inc. stock performs in rising dollar environmentLong Setup & Accurate Buy Signal Alerts - newser.com
Is Revolution Medicines Inc. stock a bargain at current levelsEarnings Recap Summary & Consistent Profit Trading Strategies - newser.com
Revolution Medicines Inc. stock trend outlook and recovery pathWeekly Profit Summary & Consistent Income Trade Ideas - newser.com
Published on: 2025-11-02 01:57:56 - newser.com
Real time scanner hits for Revolution Medicines Inc. explained2025 Price Targets & Smart Allocation Stock Reports - newser.com
What to expect from Revolution Medicines Inc. Equity Warrant in the next 30 daysJuly 2025 Weekly Recap & Free Daily Entry Point Trade Alerts - newser.com
Revolution Medicines, Inc. (RVMD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Revolution Medicines Inc. Equity Warrant showing signs of accumulationQuarterly Profit Report & Free Safe Capital Growth Stock Tips - newser.com
Developing predictive dashboards with Revolution Medicines Inc. Equity Warrant dataWatch List & Safe Entry Point Identification - newser.com
What high frequency data says about Revolution Medicines Inc.Recession Risk & Risk Controlled Stock Alerts - newser.com
What institutional flow reveals about Revolution Medicines Inc. Equity WarrantPortfolio Update Report & Advanced Swing Trade Entry Alerts - newser.com
Why Revolution Medicines Inc. stock is in analyst buy zoneJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com
Detecting price anomalies in Revolution Medicines Inc. with AIJuly 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
Is a relief rally coming for Revolution Medicines Inc. holdersMarket Movement Recap & Fast Entry Momentum Alerts - newser.com
Measuring Revolution Medicines Inc. Equity Warrant’s beta against major indicesEarnings Performance Report & Free Low Drawdown Momentum Trade Ideas - newser.com
Visual analytics tools that track Revolution Medicines Inc. Equity Warrant performanceMarket Weekly Review & Low Risk Growth Stock Ideas - newser.com
Why Revolution Medicines Inc. (42Z) stock is a strong analyst pickMarket Activity Report & Low Risk Entry Point Guides - newser.com
Revolution Medicines’ RASolve 301 Study: A Potential Game-Changer for NSCLC Treatment - TipRanks
Will RVMD's Latest FDA Win Signal a Turning Point in Its Rare Cancer Strategy? - Yahoo Finance
Chart based analysis of Revolution Medicines Inc. Equity Warrant trends2025 Big Picture & Safe Entry Momentum Tips - newser.com
How to build a custom watchlist for Revolution Medicines Inc. Equity Warrant2025 Historical Comparison & Stock Market Timing Techniques - newser.com
Order flow analysis tools used on Revolution Medicines Inc.2025 Volatility Report & Fast Entry and Exit Trade Plans - newser.com
Published on: 2025-10-31 03:39:04 - newser.com
How analysts rate Revolution Medicines Inc. stock todayEarnings Performance Report & Free Community Supported Trade Ideas - newser.com
Revolution Medicines, Inc. (RVMD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
How Revolution Medicines Inc. (42Z) stock reacts to weak economy2025 Major Catalysts & Entry Point Confirmation Signals - newser.com
Applying sector rotation models to Revolution Medicines Inc. Equity Warrant2025 Big Picture & Short-Term High Return Strategies - newser.com
Revolution Medicines Inc Stock (RVMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):